Media stories about Agilent Technologies (NYSE:A) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Agilent Technologies earned a coverage optimism score of 0.23 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 45.0359355163462 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the news headlines that may have effected Accern Sentiment’s scoring:
- Gene Editing Technologies Market to Represent Significant Revenue Growth 2017–2025 (sbwire.com)
- Here Are The Largest Companies in America With Zero Black People on Their Boards (blackenterprise.com)
- Agilent Technologies, Inc. (A) 19.54% off from 200- SMA – Voice Of Analysts (analystsbuzz.com)
- Should You Buy Agilent Technologies, Inc. (A) or Quest Diagnostics Incorporated (DGX)? – StockNewsGazette (stocknewsgazette.com)
- Microfluidic devices Market Major Influencing Key Players – Abbott, Agilent technologies, Inc, Bio-Rad Laboratories, Inc., Cepheid, Dolomite Centre (medgadget.com)
Agilent Technologies (NYSE A) traded down 0.18% on Friday, reaching $65.02. The company’s stock had a trading volume of 1,588,439 shares. The stock has a market cap of $20.94 billion, a price-to-earnings ratio of 33.53 and a beta of 1.30. The firm’s 50-day moving average price is $61.64 and its 200-day moving average price is $57.50. Agilent Technologies has a 52-week low of $42.92 and a 52-week high of $65.68.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share. On average, equities analysts expect that Agilent Technologies will post $2.32 earnings per share for the current year.
A has been the topic of a number of research analyst reports. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a report on Monday, July 10th. Jefferies Group LLC lifted their price objective on Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a report on Tuesday, May 23rd. Deutsche Bank AG reissued a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a report on Thursday, June 22nd. BTIG Research lifted their price objective on Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a report on Wednesday, May 24th. Finally, Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a report on Tuesday, May 16th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Agilent Technologies has an average rating of “Buy” and a consensus price target of $63.91.
In other news, Director Heidi Fields sold 8,625 shares of Agilent Technologies stock in a transaction on Friday, June 16th. The shares were sold at an average price of $59.53, for a total transaction of $513,446.25. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Didier Hirsch sold 72,545 shares of Agilent Technologies stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 141,098 shares of company stock valued at $8,798,933.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.